These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 32000514)

  • 1. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of BERLIN VT study: a multicenter randomised trial comparing preventive versus deferred ablation of ventricular tachycardia.
    Tilz RR; Kuck KH; Kääb S; Wegscheider K; Thiem A; Wenzel B; Willems S; Steven D
    BMJ Open; 2019 May; 9(5):e022910. PubMed ID: 31072848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.
    Žižek D; Mrak M; Jan M; Zupan Mežnar A; Ivanovski M; Žlahtič T; Kajdič N; Antolič B; Klemen L; Skale R; Avramovič Gregorič J; Štublar J; Pernat A; Šinkovec M
    Europace; 2024 May; 26(5):. PubMed ID: 38657209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
    Della Bella P; Baratto F; Vergara P; Bertocchi P; Santamaria M; Notarstefano P; Calò L; Orsida D; Tomasi L; Piacenti M; Sangiorgio S; Pentimalli F; Pruvot E; De Sousa J; Sacher F; Tritto M; Rebellato L; Deneke T; Romano SA; Nesti M; Gargaro A; Giacopelli D; Peretto G; Radinovic A
    Circulation; 2022 Jun; 145(25):1829-1838. PubMed ID: 35369700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only.
    Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S
    Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    Arenal Á; Ávila P; Jiménez-Candil J; Tercedor L; Calvo D; Arribas F; Fernández-Portales J; Merino JL; Hernández-Madrid A; Fernández-Avilés FJ; Berruezo A
    J Am Coll Cardiol; 2022 Apr; 79(15):1441-1453. PubMed ID: 35422240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial.
    Sapp JL; Tang ASL; Parkash R; Stevenson WG; Healey JS; Wells G
    Am Heart J; 2024 Aug; 274():1-10. PubMed ID: 38649085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive versus deferred catheter ablation of myocardial infarct-associated ventricular tachycardia: A meta-analysis.
    Kampaktsis PN; Doulamis IP; Tzani A; Cheung JW
    Heart Rhythm O2; 2020 Oct; 1(4):275-282. PubMed ID: 34113881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
    N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of catheter ablation in patients with post-infarct cardiomyopathy undergoing defibrillator implantation.
    Kheiri B; Simpson TF; Nazer B
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):171-175. PubMed ID: 33188524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Krisai et al Regarding Article, "Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial".
    Krisai P; Vlachos K; Jaïs P
    Circulation; 2020 Sep; 142(12):e184-e185. PubMed ID: 32955936
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.
    Atti V; Vuddanda V; Turagam MK; Vemula P; Shah Z; Nagam H; Yandrapalli S; Jazayeri MA; Koerber S; Gonzalez JV; Natale A; Di Biase L; Lakkireddy DR
    J Interv Card Electrophysiol; 2018 Nov; 53(2):207-215. PubMed ID: 29680972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply by Kuck to Letter Regarding Article, "Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial".
    Kuck KH
    Circulation; 2020 Sep; 142(12):e186. PubMed ID: 32955934
    [No Abstract]   [Full Text] [Related]  

  • 19. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial.
    Di Biase L; Burkhardt JD; Lakkireddy D; Carbucicchio C; Mohanty S; Mohanty P; Trivedi C; Santangeli P; Bai R; Forleo G; Horton R; Bailey S; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Pelargonio G; Hongo RH; Beheiry S; Hao SC; Reddy M; Rossillo A; Themistoclakis S; Dello Russo A; Casella M; Tondo C; Natale A
    J Am Coll Cardiol; 2015 Dec; 66(25):2872-2882. PubMed ID: 26718674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.